Medlive Technology Co., Ltd.

Equities

2192

KYG5961B1041

Advertising & Marketing

Market Closed - Hong Kong S.E. 04:09:13 2024-04-23 am EDT 5-day change 1st Jan Change
7.87 HKD +5.64% Intraday chart for Medlive Technology Co., Ltd. +6.93% -7.19%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Medlive Technology Co., Ltd. Proposes Final Dividend for the Year Ended December 31, 2023, Payable on June 24, 2024 CI
Medlive Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Medlive Technology to Double Profit in 2023 MT
Medlive Technology Co., Ltd. Provides Earnings Guidance for the Year Ended 31 December 2023 CI
Medlive to Buy 60% of Chinese Pharma Consulting Firm for Some 34 Million Yuan MT
Medlive Technology’s Profit Soars 266% in H1 MT
Medlive Technology Co., Ltd. Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 04 December 2023 CI
Medlive Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Medlive Technology to More than Triple H1 Profit MT
Medlive Technology Co., Ltd. Provides Earnings Guidance for the Six Months Ended 30 June 2023 CI
Medlive Technology Unit to Buy 50% Stake in Beijing SCMedcon MT
Medlive Technology Co., Ltd. Announces Executive Changes CI
Medlive Technology Co., Ltd. Announces Director Changes CI
Medlive Technology Co., Ltd. Proposes Final Cash Dividend for the Year Ended December 31, 2022, Payable on July 10, 2023 CI
Medlive Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Medlive Technology's Profit to Rise in 2022 MT
Medlive Technology Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ended 31 December 2022 CI
M3's Fiscal Nine-month Attributable Profit Drops 30% on Increased Operating Costs MT
Medlive Technology Sees No Explanation For Unusual Share Price Movement MT
M3's Fiscal H1 Attributable Profit Plunges 41% on High-base Effect MT
Medlive Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
M3's Fiscal Q1 Attributable Profit Tumbles 23% on High-base Effect; Shares Rise 13% MT
Certain Ordinary Shares of Medlive Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 14-JUL-2022. CI
Medlive Technology Buys 60% of Beijing Focus Innovation for $7.2 Million MT
Medlive Technology Co., Ltd. Proposes Final Cash Dividend for the Year Ended December 31, 2021, Payable on July 11, 2022 CI
Chart Medlive Technology Co., Ltd.
More charts
Medlive Technology Co Ltd is a China-based investment holding company mainly operates online professional physician platform. The Company mainly operates three segments. Its Precision Marketing and Corporate Solutions segment provides precision marketing solutions and corporate solutions. Its precision marketing solutions include digital detailing, digital marketing consulting and digital content creation services. Its revenue of its corporate solutions is primarily software as a service (SaaS). The Medical Knowledge Solutions segment mainly provides professional medical information and medical software services. The Intelligent Patient Management Solutions segment mainly provides online patient consultation and prescription services and patient management services. The Company mainly conducts its business within domestic market.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
6.887 CNY
Average target price
9.314 CNY
Spread / Average Target
+35.24%
Consensus
  1. Stock Market
  2. Equities
  3. 2192 Stock
  4. News Medlive Technology Co., Ltd.
  5. Medlive Technology Sees No Explanation For Unusual Share Price Movement